Machine learning can expedite diagnosis of colorectal cancer

A machine learning tool could help physicians in predicting the onset of colorectal cancer as much as a year before the cancer progresses, according to a study published in Digestive Diseases and Sciences. 

The ColonFlag tool uses machine learning to detect colon cancer. This study evaluated the tool’s accuracy in cancer detection using blood samples and information including the patient’s gender and age.

The study included data from 900 colorectal cancer patients and 9,108 control patients. ColonFlag then analyzed patient’s blood count, gender and age to determine rick of developing colorectal cancer.

Results showed the tool was able to identify patients with a 10-fold higher risk of developing cancer at its earliest stages, from 180 to 360 days before clinical diagnosis. Additionally, the tool was more effective in identifying patients at risk of right-sided cancers.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.